Oracle and Epic Deepen Health Tech Push as Hospitals Modernize

LONDON — May 24, 2026 — Hospital systems are accelerating consolidation of clinical, administrative, and AI workloads onto a smaller set of health technology platforms, reshaping vendor economics across the sector.

Executive Summary

• Global digital health spending continues to expand at double-digit rates, with electronic health record modernization, ambient clinical documentation, and revenue cycle automation absorbing the largest share of enterprise budgets.
• Oracle Health, Epic Systems, and Veeva are competing with hyperscalers including Amazon Web Services and a cohort of AI-native entrants over control of the clinical data layer.
• Ambient AI scribes have become the fastest-adopted clinical AI category, with health systems reporting measurable reductions in documentation burden.
• Regulatory frameworks in the United States and European Union are tightening around algorithmic transparency, data residency, and post-market surveillance of AI-enabled medical devices.
• Procurement decisions are shifting from departmental purchases to enterprise platform commitments, raising the stakes for interoperability and vendor lock-in.

Key Takeaways

• Health tech is moving from a clinical IT line item to board-level infrastructure strategy.
• The competitive frontier has shifted from features to data architecture and AI governance.
• Interoperability standards, particularly HL7 FHIR, are now decisive in vendor selection.
• Reimbursement and labor shortages, not technology capability, remain the dominant constraints on adoption.

A Sector Repositioned as Critical Infrastructure

Health technology has crossed a threshold familiar to other regulated industries: it is no longer treated as a departmental function reporting to the chief information officer, but as core operating infrastructure with direct implications for clinical outcomes, margin, and regulatory standing. Hospital executives are negotiating multi-year platform agreements that bundle electronic health records, analytics, revenue cycle, and increasingly, generative AI capabilities. The shift is partly a response to financial pressure. U.S. hospital operating margins have remained compressed since the post-pandemic labor cost reset, and European systems are contending with capacity constraints driven by demographic aging. Both environments reward technology that reduces clinician time per encounter, accelerates billing cycles, and lowers the marginal cost of administrative throughput. Health technology vendors that can credibly demonstrate operating leverage, not just feature parity, are capturing disproportionate share.

Key Market Trends for Health Tech in 2026

Trend	Primary Driver	Adoption Stage	Enterprise Impact
Ambient AI documentation	Clinician burnout, throughput	Scaling	High
Cloud-native EHR migration	Legacy cost, AI readiness	Mid-stage	High
Revenue cycle automation	Margin pressure	Mainstream	High
Remote patient monitoring	Value-based care contracts	Expanding	Medium
Genomic data platforms	Precision medicine pipelines	Early	Medium
FHIR-based interoperability	Regulatory mandate	Mainstream	High

The Competitive Structure

The vendor landscape resolves into three tiers. For our smart farming market analysis, At the core, Epic Systems and Oracle Health control the majority of acute-care electronic health record installations across large U.S. integrated delivery networks, with Epic continuing to extend its share among academic medical centers and Oracle pursuing modernization of the former Cerner installed base on Oracle Cloud Infrastructure. A second tier of cloud and data platforms, led by Amazon Web Services, Microsoft, and Google Cloud, competes to host clinical workloads, power analytics, and supply foundation models for clinical AI applications. A third tier of specialists, including Veeva Systems in life sciences, Doximity in clinician networking, Tempus AI in oncology data, and a deep bench of ambient documentation startups, occupies high-value niches. According to Judy Faulkner, founder and chief executive of Epic Systems, the company's strategy continues to emphasize a tightly integrated suite over best-of-breed assembly, a position that has historically resonated with chief information officers seeking to reduce integration overhead. Oracle, by contrast, is positioning its health portfolio as a cloud-first modernization play, with chairman Larry Ellison publicly framing the Cerner acquisition as a multi-decade infrastructure bet. "Ambient documentation is the first generative AI use case in healthcare where the return on investment is unambiguous and the clinician adoption curve is genuinely steep," noted a senior analyst at Gartner covering provider IT, citing reductions in after-hours charting time reported across multiple health system pilots. Forrester research has similarly identified clinical documentation and prior authorization as the two AI categories most likely to reach enterprise-wide deployment within the current planning cycle.

Where AI Is Actually Landing

The practical footprint of artificial intelligence in healthcare in 2026 is narrower and more disciplined than the rhetoric of two years ago suggested. Ambient AI scribes from vendors including Abridge, Nuance (now part of Microsoft), and Suki have moved from pilot to enterprise rollout at large systems. Revenue cycle automation, including coding assistance and denial management, has emerged as a second productive category, driven by measurable cash collection improvements. Imaging AI remains active but fragmented, with hundreds of FDA-cleared algorithms competing for radiology workflow attention. What has not materialized at scale is autonomous clinical decision-making. Regulators in both Washington and Brussels have signaled that AI systems influencing diagnosis or treatment will face escalating post-market surveillance obligations, and health system general counsels are correspondingly cautious. The result is a market in which AI is deployed to remove administrative friction rather than to replace clinical judgment, and where governance committees, not procurement teams, increasingly determine which models reach production. These dynamics align with broader Health Tech trends visible across enterprise deployments.

Interoperability and the Data Layer

The HL7 FHIR standard has become the de facto interoperability protocol, reinforced by regulatory pressure from the Office of the National Coordinator for Health IT in the United States and by European Health Data Space provisions advancing through EU member states. Vendor differentiation is increasingly a function of how cleanly a platform exposes FHIR APIs, supports bulk data export, and integrates with health information exchanges. This matters commercially because the data layer determines who captures AI value. A platform that controls the longitudinal patient record can train, fine-tune, and govern models with less friction than a third-party application reliant on negotiated data access. According to a chief information officer at a large U.S. academic medical center, quoted in industry coverage, vendor evaluations now weight data architecture and AI governance roadmap as heavily as traditional clinical functionality.

Competitive Landscape

Vendor	Primary Position	Core Strength	Strategic Risk
Epic Systems	EHR incumbent	Integrated suite, clinician loyalty	Premium pricing, closed ecosystem perception
Oracle Health	EHR challenger	Cloud infrastructure, global footprint	Cerner migration execution
Microsoft	AI and productivity layer	Nuance, Azure, OpenAI partnership	Channel dependence on EHR vendors
Amazon Web Services	Cloud and data services	HealthLake, scale, partner network	Limited clinical workflow presence
Veeva Systems	Life sciences cloud	Industry specialization	Adjacent expansion challenges
Tempus AI	Oncology data and diagnostics	Multimodal clinical datasets	Path to sustained profitability

Governance, Regulation, and Risk

The regulatory perimeter around health technology is tightening on three fronts. The U.S. Food and Drug Administration continues to refine its framework for AI/ML-enabled medical devices, with greater emphasis on predetermined change control plans and real-world performance monitoring. The HIPAA security framework is undergoing its most substantive update in over a decade, raising the baseline for encryption, access controls, and incident response. In Europe, the AI Act's high-risk classification captures most clinical decision support applications, layering documentation and transparency obligations on top of MDR requirements. For enterprise buyers, the practical implication is that procurement diligence now extends well beyond functional fit. Algorithmic bias testing, model card documentation, data lineage, and breach notification capability are increasingly contractual line items. Vendors unable to supply this documentation are being filtered out earlier in selection processes. Readers tracking the latest Health Tech innovations will note that governance maturity is becoming a competitive moat in its own right.

Outlook

The near-term trajectory of health technology is shaped less by novel capability than by the disciplined operationalization of capabilities already demonstrated. For ai sector intelligence, Ambient documentation will continue to scale, revenue cycle AI will expand, and EHR modernization will absorb a substantial share of capital budgets through the remainder of the decade. The structural question is whether the incumbent EHR vendors retain their gatekeeper role as AI workloads migrate to hyperscaler infrastructure, or whether the cloud and data platforms gradually disintermediate them at the application layer. "The most consequential decisions in healthcare technology over the next three years will be about data architecture, not features," observed a research director at IDC Health Insights in published commentary, a view echoed by multiple health system chief information officers in recent industry surveys. For boards and executive teams, the implication is that health technology strategy now belongs alongside cybersecurity and clinical operations as a standing agenda item rather than a periodic procurement review.

Related Coverage

• More Health Tech Analysis

Disclosure: Business 2.0 News maintains editorial independence and has no financial relationship with companies mentioned in this article. (See also: related sustainability coverage.)

Sources include company disclosures, regulatory filings, analyst reports, and industry briefings. Figures referenced in this analysis are drawn from publicly available market research and have been cross-referenced with multiple independent analyst estimates.